NAME: Levtchenko Elena
Born: 3th of April 1965 in Moscow
University Education
1982-1988: Russian Medical University
Obtained certificate/diploma: MD cum laude
Thesis:
“Specific aspects of diabetes mellitus in children”
1988-1991: Paediatrics Research Institute of Academy of Medical Science – Moscow
Residence in Paediatrics
1991-1993: Free University of Brussels (VUB) – Belgium
Master programme in Medical and Pharmacological Research.
Thesis:
“Investigation of Pro-insulin in Isolated Human ß-Cells and Human Pancreatic Extracts”
Obtained diploma:
Master of Medical and Pharmaceutical Research
1993-1997: VUB-Brussels: Residence in Paediatrics
Obtained licence: Paediatrician
1998 – 2001 Radboud University Medical Centre, Nijmegen, The Netherlands
Fellowship in Paediatric Nephrology
Obtained licence: Paediatric Nephrologist
2001- 2005 Radboud University Medical Centre , Nijmegen, The Netherlands
PhD project “Cystinosis: improved medical care and new insights into pathogenesis” (promoter: Prof. Dr. Leo Monnens)
Obtained degree: PhD (30th of March, 2006).
Work experience
2005-2008 Radboud University Medical Centre , Nijmegen, The Netherlands
Assistant professor in the department of paediatric nephrology
2003-now Coordination of national cystinosis outpatient clinic in The Netherlands
2008-now University Hospital Leuven, Belgium
Adjunct head of the department of paediatric nephrology
Other activities
2002 – now Medical advisor of Cystinosis Group Netherlands
2004 – now Medical advisor of International Cystinosis Patients Foundation
2005 – now Medical advisor of commission Genetic Renal Diseases of Dutch Patients Association
2007 – now Member of the Council of European Society of Paediatric Nephrology
2006 – now Section Editor of the journal “Pediatric Nephrology”
2008-now Member of the scientific board of Cystinosis Research Foundation (USA)
2009-now Member of the scientific board of Dutch Kidney Foundation
Scientific output
Publications in peer-reviewed journals
1. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis-a review.
Löwik MM, Groenen PJ, Levtchenko EN, Monnens LA, van den Heuvel LP.
Eur J Pediatr, 2009, 168:1291-304.
2. EUNEFRON, the European Network for the Study of Orphan Nephropathies.
Devuyst O, Meij I, Jeunemaitre X, Ronco P, Antignac C, Christensen EI, Knoers NV, Levtchenko EN, Deen PM, Müller D, Wagner CA, Rampoldi L, van’t Hoff WG; EUNEFRON consortium.
Nephrol Dial Transplant, 2009, 24: 2011-5.
3. *Fertility status in male cystinosis patients treated with cysteamine.
Besouw MT, Kremer JA, Janssen MC, Levtchenko EN.
Fertil Steril, 2009, febr.
4. Antibiotic prophylaxis for children with primary vesicoureteral reflux: where do we stand today?
Costers M, Van Damme-Lombaerts R, Levtchenko E, Bogaert G.
Adv Urol, 2008: 217805.
5. Gitelman syndrome.
Knoers NV, Levtchenko EN.
Orphanet J Rare Dis, 2008; 3-22.
6. *Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.
Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ.
Pediatr Nephrol, 2008, 23; 2013-20.
7. *Evaluation of the proximal tubular function in hereditary renal Fanconi syndrome.
Monnens L, Levtchenko E.
Nephrol Dial Transplant, 2008, 23: 2719-22.
8. *Mitochondrial complex V expression and activity in cystinotic fibroblasts.
Wilmer MJ, van den Heuvel LP, Rodenburg RJ, Vogel RO, Nijtmans LG, Monnens LA,
Levtchenko E.
Pediatr Res, 2008, 64: 495-7.
9. *Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.
Bockenhauer D, Bokenkamp A, van’t Hoff W, Levtchenko E, Kist-van Holthe JE, Tasic V,
Ludwig M.
Clin J Am Soc Nephrol, 2008, 3: 1430-6.
10. *Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis.
Wilmer MJ, Christensen EI, van den Heuvel LP, Monnens LA, Levtchenko EN.
Am J Kidney Dis, 2008, 51: 893-903.
11. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
Löwik M, Levtchenko E, Westra D, Groenen P, Steenbergen E, Weening J, Lilien M, Monnens L, van den Heuvel L.
Nephrol Dial Transplant, 2008, 23: 3146-51.
12. *The use of CDME in cystinosis research.
Wilmer MJ, van den Heuvel LP, Levtchenko EN.
Neurochem Res, 2008, 33: 2373-4.
13. *Identification and subcellular localization of a new cystinosin isoform.
Taranta A, Petrini S, Palma A, Mannucci L, Wilmer MJ, De Luca V, Diomedi-Camassei F, Corallini S, Bellomo F, van den Heuvel LP, Levtchenko EN, Emma F.
Am J Physiol Renal Physiol, 2008, 294: 1101-8.
14. *Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene.
Wamelink MM, Struys EA, Jansen EE, Levtchenko EN, Zijlstra FS, Engelke U, Blom HJ, Jakobs C, Wevers RA.
Hum Mutat, 2008, 29: 532-6.
15. From gene to disease; Dent’s disease caused by abnormalities in the CLCN5 and OCRL1 genes.
Levtchenko EN, Monnens LA, Bökenkamp A, Knoers NV.
Ned Tijdschr Geneeskd, 2007, 151: 2377-80.
16. Growth charts for Wolf-Hirschhorn syndrome (0-4 years of age).
Antonius T, Draaisma J, Levtchenko E, Knoers N, Renier W, van Ravenswaaij C.
Eur J Pediatr, 2008, 167: 807-10.
17. *P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury.
Huls M, Kramers C, Levtchenko EN, Wilmer MJ, Dijkman HB, Kluijtmans LA, van der Hoorn JW, Russel FG, Masereeuw R.
Kidney Int, 2007, 72: 1233-41.
18. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation.
Löwik MM, Groenen PJ, Pronk I, Lilien MR, Goldschmeding R, Dijkman HB, Levtchenko EN, Monnens LA, van den Heuvel LP.
Kidney Int, 2007, 72: 1198-203.
19. *Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?
Besouw MT, Levtchenko EN, Willemsen MA, Noordam K.
Pediatr Nephrol, 2008, 23: 307-10.
20. *Cystine dimethylester model of cystinosis: still reliable?
Wilmer MJ, Willems PH, Verkaart S, Visch HJ, de Graaf-Hess A, Blom HJ, Monnens LA, van den Heuvel LP, Levtchenko EN.
Pediatr Res, 2007, 62: 151-5.
21. *The origin of halitosis in cystinotic patients due to cysteamine treatment.
Besouw M, Blom H, Tangerman A, de Graaf-Hess A, Levtchenko E.
Mol Genet Metab, 2007, 91: 228-33.
22. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF.
Am J Kidney Dis, 2007, 49: 592-7.
23. From gene to disease; ‘apparent mineralocorticoid excess’ syndrome, a syndrome with an apparent excess of mineral corticoids
Levtchenko EN, Deinum J, Knoers NV, Hermus AR, Monnens LA, Lenders JW.
Ned Tijdschr Geneeskd, 2007, 24;151: 692-4.
24. *Successful treatment of respiratory dysfunction in cystinosis by nocturnal non-invasive positive pressure ventilation.
Edens MA, van Son WJ, de Greef MH, Levtchenko EN, Blijham T, Wijkstra PJ.
Clin Nephrol, 2006, 66: 306-9.
25. From gene to disease; hypophosphataemic rickets and the PHEX gene
Monnens L, Levtchenko E.
Ned Tijdschr Geneeskd, 2006, 150: 2058-9.
26. Glomerular involution in children with frequently relapsing minimal change nephrotic syndrome: an unrecognized form of glomerulosclerosis?
Dijkman HB, Wetzels JF, Gemmink JH, Baede J, Levtchenko EN, Steenbergen EJ.
Kidney Int, 2007, 71: 44-52.
27. No evidence of hearing loss in pseudohypoaldosteronism type 1 patients.
Peters TA, Levtchenko E, Cremers CW, Curfs JH, Monnens LA.
Acta Otolaryngol, 2006, 126: 237-9.
28. *Development of Fanconi syndrome during infancy in a patient with cystinosis.
Levtchenko E, Monnens L.
Acta Paediatr, 2006, 95: 379-80.
29. *Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts.
Levtchenko EN, Wilmer MJ, Janssen AJ, Koenderink JB, Visch HJ, Willems PH, de Graaf-Hess A, Blom HJ, van den Heuvel LP, Monnens LA.
Pediatr Res, 2006, 59: 287-92.
30. *Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.
Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ.
Pediatr Nephrol, 2006, 21: 110-3.
31. *Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells.
Wilmer MJ, de Graaf-Hess A, Blom HJ, Dijkman HB, Monnens LA, van den Heuvel LP, Levtchenko EN.
Biochem Biophys Res Commun, 2005, 337: 610-4.
32. A genetic childhood disease with consequences in adult life: the Denys-Drash syndrome.
Löwik MM, van den Berkmortel FW, Noordam C, van Hamersvelt HW, van den Heuvel LP, Levtchenko EN.
Ned Tijdschr Geneeskd, 2005, 149: 1751-5.
33. *Altered status of glutathione and its metabolites in cystinotic cells.
Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H.
Nephrol Dial Transplant, 2005, 20: 1828-32.
34. Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy.
Bongers EM, Huysmans FT, Levtchenko E, de Rooy JW, Blickman JG, Admiraal RJ, Huygen PL, Cruysberg JR, Toolens PA, Prins JB, Krabbe PF, Borm GF, Schoots J, van Bokhoven H, van Remortele AM, Hoefsloot LH, van Kampen A, Knoers NV.
Eur J Hum Genet, 2005, 13: 935-46.
35. Lithium, a potentially dangerous drug.
Monnens LA, Levtchenko E.
Ned Tijdschr Geneeskd, 2005, 149: 1019.
36. Renal transplant nephrectomy in children: can an aggressive approach be recommended?
Zerouali F, Levtchenko EN, Feitz WF, Cornelissen EA, Monnens LA.
Pediatr Transplant, 2004, 8: 561-4.
37. *Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy.
Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H.
Clin Chem, 2004, 50: 1686-8.
38. Growth hormone therapy influences endothelial function in children with renal failure.
Lilien MR, Schröder CH, Levtchenko EN, Koomans HA.
Pediatr Nephrol, 2004, 19: 785-9.
39. *From gene to disease: cystinosis.
Levtchenko EN, Wilmer M, de Graaf-Hess AC, van den Heuvel LP, Blom H, Monnens LA.
Ned Tijdschr Geneeskd, 2004, 148: 476-8.
40. *ACE inhibitorenalapril diminishes albuminuria in patients with cystinosis.
Levtchenko E, Blom H, Wilmer M, van den Heuvel L, Monnens L.
Clin Nephrol, 2003, 60: 386-9.
41. Distinction between Liddle syndrome and apparent mineralocorticoid excess.
Monnens L, Levtchenko E.
Pediatr Nephrol, 2004, 19: 118-9.
42. From gene to disease; SLC3A1, SLC7A9 and cystinuria.
Geelen J, Levtchenko E, Monnens L.
Ned Tijdschr Geneeskd, 2003, 147: 1242-3.
43. Effective chemical preservation of morphology of urinary erythrocytes.
Komarova O, van der Meer W, Levtchenko E, Monnens L.
Pediatr Nephrol, 2003, 18: 665-6.
44. WT-1 and NPHS2 mutation analysis in patients with non-familial steroid-resistant focal-segmental glomerulosclerosis.
Löwik MM, Levtchenko EN, Monnens LA, van den Heuvel LP.
Clin Nephrol, 2003, 59: 143-6.
45. *Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM, Monnens LA, Levtchenko EN.
Nephrol Dial Transplant, 2002, 17: 1766-70.
46. *Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
Levtchenko EN, de Graaf-Hess A, Blom HJ, Monnens LA.
Clin Nephrol, 2002, 57: 349-51.
47. Treatment of children with acute pyelonephritis: a prospective randomized study.
Levtchenko E, Lahy C, Levy J, Ham H, Piepsz A.
Pediatr Nephrol, 2001, 16: 878-84.
48. *The molecular basis of Dutch infantile nephropathic cystinosis.
Heil SG, Levtchenko E, Monnens LA, Trijbels FJ, Van der Put NM, Blom HJ.
Nephron, 2001, 89: 50-5.
49. Role of Tc-99m DMSA scintigraphy in the diagnosis of culture negative pyelonephritis.
Levtchenko EN, Lahy C, Lévy J, Ham HR, Piepsz A.
Pediatr Nephrol, 2001, 16: 503-6.
50. Bowel perforation due to hypotension in an infant with prune belly syndrome undergoing peritoneal dialysis.
Levtchenko E, Pardede SO, Monnens L.
Perit Dial Int, 1999, 19: 492.
51. Attitude of Belgian pediatricians toward strategy in acute pyelonephritis.
Levtchenko EN, Ham HR, Levy J, Piepsz A.
Pediatr Nephrol, 2001, 16: 113-5.
52. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
te Loo DM, Levtchenko E, Furlan M, Roosendaal GP, van den Heuvel LP.
Pediatr Nephrol, 2000, 14: 762-5.
53. Nutritional value of an “anti-regurgitation” formula.
Levtchenko E, Hauser B, Vandenplas Y.
Acta Gastroenterol Belg, 1998, 61: 285-7.
54. Exogenous surfactant therapy for status asthmaticus.
Levtchenko E, Ramet J.
Eur J Pediatr, 1997, 156: 508.
55. Ehrlichiosis in Belgium.
Pierard D, Levtchenko E, Dawson JE, Lauwers S.
Lancet, 1995, 346: 1233-4.
· Publications related to cystinosis.
Book Chapters
1. Erfelijke nierziekten.
L. Monnens, E. Levtchenko.
In Klinische Nefrologie, ed. P.C. de Jong, Elsevier, 2005.
2. Disorders of tubular electrolyte handling.
N. van Slobbe-Knoers, E. Levtchenko.
Oxford Textbook of Medicine, in Press.
3. Nephrogenic diabetes Insipidus.
N. van Slobbe-Knoers, E. Levtchenko.
Pediatric Nephrology, 2009.
4. Renal Fanconi syndrome and cystinosis.
E. Levtchenko, M. Kagan, A. Tsygin.
Russian book of Pediatric Nephrology.
In press.
Oral presentations at National conferences
1. Trois cas de “pseudo”-obstruction intestinale
E. Levtchenko, A. Vanderfaillie, M. Scaillon, Y. Vandenplas, Cadranel S.
Voordracht tijdens 10e Verjaardag van BGPGN, 22/10/94, Brussel.
2. Analgesienoden volgens ventilatie modes.
E.Levtchenko, J. Ramet
Voordracht tijdens 23e jaarlijkse vergadering van de Belgische vereniging voor kindergeneeskunde; 17-18/03/1995 – Brussels
3. First case of human ehrlichiosis in Belgium.
E. Levtchenko, D. Pierard, J. Van der Werff ten Bosch, P.Bollen, J.De Schepper, S.Lauwers
Voordracht tijdens de24e jaarlijkse vergadering van de “Belgische vereniging voor kindergeneeskunde”; 22-23/03/1996, Spa.
4. Chronic subdural haematoma in infants: a sign of the whiplash shaken baby syndrome?
E. Levtchenko, Rayen I, Rosseneu S, Denolf D, De Schepper J.
Voordracht tijdens de24e jaarlijkse vergadering van de “Belgische vereniging voor kindergeneeskunde”; 22-23/03/1996, Spa.
5. Urine cysteamine verlies bij cystinose patiënten is verwaarloosbaar.
E. Levtchenko, L. Monnens, H. Blom
Voordracht tijdens Najaarssymposium van de Vereniging Erfelijke Stofwisselingsziekte Nederland. Oktober 8-10, 2000, Noordwijkerhout.
6. Follow-up en behandeling van volwassene cystinose patiënten in Nederland.
J. Geelen, L.Monnens, E. Levtchenko
Voordracht tijdens Najaarssymposium van de Vereniging Erfelijke Stofwisselingsziekte Nederland. Oktober 8-10, 2000, Noordwijkerhout
7. Glomerular disease due to WT-1 gene mutations
E. Levtchenko
Voordracht tijdens het Symposium “Hereditary glomerular disease: from genes to therapy” ter gelegenheid van 25 jaar kindernefrologie/kinderdialyse in Nijmegen
Nijmegen, Oktober 10, 2003.
8. ATP depletion and increased oxidised glutathione in cultured cystinotic fibtoblasts.
E. Levtchenko, M. Wilmer, A. de Graaf-Hess, J. Koenderink, H. Blom, L. van den Heuvel, Monnens L
Voordracht tijdens Nederlandse nefrologie Dagen 2004
Veldhoven, 25 Maart, 2004
9. DNA onderzoek bij kinderen met nefrotisch syndroom.
E. Levtchenko
Uitgenodigde spreker tijdens de jaarlijkse themamiddag van Commissie Nefrotisch syndroom van Nierpatiënten Vereniging Nederland.
Ede, 2 April, 2005
10. No depletion of intracellular ATP in proximal tubuli derived from urine of cystinosis patients.
E. Levtchenko, M. Wilmer, A. de Graaf-Hess, H. Blom, L. Monnens, L. van den Heuvel
Voordracht tijdens Nederlandse nefrologie Dagen 2005
Veldhoven, April 5-6, 2005
11. Culture of proximal tubular cells from urine of patients with Fanconi syndrome.
E. Levtchenko, M. Wilmer, A. de Graaf-Hess, H. Blom, L. Monnens, L. van den Heuvel
Voordracht tijdens Nederlandse nefrologie Dagen 2005
Veldhoven, April 5-6, 2005
12. Decreased intracellular ATP levels in conditionally immortalized proximal tubular cells from cystinotic patients.
M. Wilmer, L. van den Heuvel, A. de Fraaf-Hess, H. Blom, L. Monnens, E. Levtchenko
Voordracht tijdens Nederlandse nefrologie Dagen 2006
Veldhoven, April 4-5, 2006
13. Glomerulaire involutie bij kinderen met een nefrotisch syndroom: een nieuwe vorm van globale glomerulosclerose.
E. Levtchenko, H. Dijkman, J. Baede, E. Steenbergen, J. Wetzels
Voordracht tijdens het jaarlijks Congres van Nederlandse Vereniging Kindergeneeskunde 2006
Veldhoven, November 1-3, 2006
14. Cysteamine treatment improves oxidative stress in cystinotic proximal tubular cells.
Annual meeting of Belgian society of nephrology
Brussels, 23 April, 2009
15. Proximal tubular cell model expressing functional transporters.
Annual meeting of Belgian Society of Nephrology
Brussels, April 23, 2009
16. Long-term outcome of frequently relepsing nephritic syndrome in children.
Annual meeting of Belgian Society of Nephrology
Leuven, April 23, 2009
Oral presentations at international conferences
1. Cystinose sans accumulation de cystine en leucocytes.
E. Levtchenko, H. Blom, A. Van de Vlucht, A. De Graaf, L. Monnens
Voordracht tijdens Seminaire de Nephrologie Pediatrique, 22-23/03/99, Parijs.
2. Treatment of children with acute pyelonephritis: a prospective randomized study.
E. Levtchenko, C. Lahy, J. Levy, M. Verboven, M. Ham, A. Piepsz
Voordracht tijdens de 34th Annual Meeting of the European Society for Paediatric Nephrology, June 18-20, 2000, Helsinki.
3. Enalapril diminishes albumin excretion in patients with cystinosis.
E. Levtchenko, M. Wilmer, H. Blom, L. van den Heuvel, L. Monnens
Voordracht tijdens de 36th Annual Meeting of the European Society for Paediatric Nephrology, September 20-23, 2002, Bilbao.
4. Use of NIMH for determination of dry weight and prevention of dialysis associated morbidity in children.
E. Levtchenko, D. Creemers, H. Van Lier, D. Van Schaijk, I. Van Rijbroek, C. Schröder
Voordracht tijdens Annual Dialysis Conference 2003
Seattle, Maart 2-4, 2003.
5. Cysine measurement with HPLC.
E. Levtchenko, A. de Graaf-Hess, H. Blom
2nd cystine quality control meting
Parijs, Februari 27, 2004
6. Comparison of cystine determination in mixed leukocytes versus polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy.
E. Levtchenko, M. Wilmer, A. de Graaf-Hess, L. van den heuvel, L. Monnens, H.Blom
Voordracht tijdnes 15th Meeting of the International Pediatric Nephrology Association
Adelaide, Augustus 29 – September 1, 2004
7. Normal energy generating capacity and bradykinin stimulated ATP production in cystinotic fibroblasts.
E. Levtchenko, M. Wilmer M, A. de Graaf-Hess, H. Blom, L. Monnens, L. van den Heuvel
Voordracht tijdens de 39th Annual Meeting of the European Society for Paediatric Nephrology, September, 13-16, 2005, Istambul
8. CDME model of cystinosis: still reliable? (Invited)
Compliance with cysteamine therapy. (Invited)
E. Levtchenko
4th International congress of Cystinosis Foundation
Noordwijkerhout, June 30 – July 2, 2006
9. Adult consequences of paediatric diseases: cystinosis. (Invited)
40th Annual meeting of European Society of Pediatric Nephrology
Palermo, October 7-10, 2006
10. Congress Chair of 4th International congress of Cystinosis Foundation
Noordwijkerhout, June 30 – July 2, 2006
11. Organiser and invited speaker of the satellite symposium Cystinosis
15th Congress of International Pediatric Nephrology Association
2010
12. ATP dysfunction in Nephropathic cystinosis (Invited)
American Cystinosis Conference
Texas, San Antonio, Texas July 19-21, 2007
13. Studying the pathogenesis of renal disease in cystinosis (Invited)
International Cystinosis Research Symposium
Irvine, April 3-4, 2008
14. Proximal tubular cell model presenting albumin and amino acid transport.
Dutch Nephrology Days
Veldhoven April 8-9, 2008
15. Proximal tubular cell model expressing functional transporters.
Annual meeting of Belgian Society of Nephrology
Leuven, April 11, 2008
16. Genetics of nephrotic syndrome. (Invited)
State of the art in pediatric nephrology
Leuven, 24 April, 2008
17. Biochemical models for cystinosis research
Dublin, 5th International cystinosis Conference, June 26-28, 2008 (Invited)
18. Renal disease in cystinosis.
Dublin, 5th International cystinosis Conference, June 26-28, 2008 (Invited)
19. Ten years anniversary of cystinosis gene. (Invited)
42th Annual meeting of European Society of Pediatric Nephrology
Lyon, 11-14 September 2008
20. Sedoheptulokinase deficiency due to homozygous 57-kb deletion in cystinosis patients:
elucidation of the function of the CARKL gene
42th Annual meeting of European Society of Pediatric Nephrology
Lyon, 11-14 September 2008
21. Renal tubular acidosis (Invited)
Spring meeting of APN
Amsterdam, 28-30 March, 2009
22. Syndrome of apparent mineralocorticoid access (Invited)
Satellite symposium of Dutch nephrology days 2009 “Monogenetic hypertension”
Veldhoven, 6-8 April, 2009
23. Studies in cell model of cystinosis (Invited)
EUNEFRON meeting
Zurich, 16-18 April, 2009
24. Nephropathic cystinosis (Invited)
World Congress of Nephrology
Milan, 22-26 May 2009
25. ATP metabolism in Nephropathic cystinosis (Invited)
Cystinosis Research Network Conference
Atlanta, 16-18 July, 2009
26. Renal disease in cystinosis (Invited)
1st International Cystinosis Conference in East Mediterranean
Ankara, 1-4 October 2009
27. Treatment of cystinosis and complications (Invited).
1st International Cystinosis Conference in East Mediterranean
Ankara, 1-4 October 2009
Awards
2004: University award for a promising female investigator ( Dr. Frye stipendium)
By Radboud University Nijmegen
2006: Young Investigator Award of Dutch Society of Pediatrics
2009: Best poster presentation award of European Society of pediatric nephrology during the 43rd Annual ESPN Conference
